Monthly Research Roundup: Immunotherapy, Childhood Cancer Survivors, and More

June Research Roundup Image 670x295

Every day American Cancer Society researchers and scientists across the world are working to find cancer cures -- and better ways to treat and prevent the disease. Below are some of the interesting stories our researchers think you should know about from June.

  • The low down on immunotherapy: The cancer research world is dedicating increasing energy to a rapidly evolving type of treatment that has the potential to be more effective than many of today’s existing options.
  • Making life better for childhood cancer survivors: Researchers are working to address the gaps in knowledge about the challenges and needs of the children, adolescents, and young adults who survive cancer. Experts revealed insights into how to improve the lives of this population at the 7th Biennial Cancer Survivorship Research Conference.
  • Moving cancer survivorship care forward: The growing number of cancer survivors requires new and improved models of care, according to American Cancer Society researcher and cancer survivorship expert Kevin Stein, Ph.D.
  • 10 need-to-know facts about cancer survivors: The new Cancer Treatment & Survivorship Facts & Figures from the American Cancer Society provides the most up to date data available on cancer survivors in the United States.
  • Pioneering lung cancer treatment trial set to start soon: In an effort to test drugs faster and more efficiently, a group of public and private partners is launching a new type of study to test 5 different experimental lung cancer drugs at the same time.
  • 3-D mammograms find more cancers: Mammograms done with 3-D technology find slightly more cancers than regular mammograms and show fewer false positives, according to a new study published in the Journal of the American Medical Association.

American Cancer Society news stories are copyrighted material and are not intended to be used as press releases. For reprint requests, please see our Content Usage Policy.